StockData
Cabaletta Bio, Inc. logo

Cabaletta Bio, Inc. (CABA) stock

CABANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 2/30
$1.28−0.05 (-3.76%)

Close on Nov 13, 2026Market cap $217.02MP/E –Yield –

Cabaletta Bio EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

For fiscal 2025 it was -$2.10. The highest annual figure on record is -$1.44 in fiscal 2020.

Annual eps

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$2.10–
FY2024Dec 31, 2024-$2.34–
FY2023Dec 31, 2023-$1.65–
FY2022Dec 31, 2022-$1.81–
FY2021Dec 31, 2021-$1.80–
FY2020Dec 31, 2020-$1.44–
FY2019Dec 31, 2019-$4.07–
FY2018Dec 31, 2018-$6.87–

Quarterly eps

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$0.28–
Q2 FY2026Jun 30, 2026-$0.34–
Q1 FY2026Mar 31, 2026-$0.39–
Q3 FY2025Sep 30, 2025-$0.44–
Q2 FY2025Jun 30, 2025-$0.73–
Q1 FY2025Mar 31, 2025-$0.71–
Q3 FY2024Sep 30, 2024-$0.62–
Q2 FY2024Jun 30, 2024-$0.56–
Q1 FY2024Mar 31, 2024-$0.51–
Q3 FY2023Sep 30, 2023-$0.37–
Q2 FY2023Jun 30, 2023-$0.37–
Q1 FY2023Mar 31, 2023-$0.45–
Q3 FY2022Sep 30, 2022-$0.39–
Q2 FY2022Jun 30, 2022-$0.45–
Q1 FY2022Mar 31, 2022-$0.45–
Q3 FY2021Sep 30, 2021-$0.45–
Q2 FY2021Jun 30, 2021-$0.45–
Q1 FY2021Mar 31, 2021-$0.41–
Q3 FY2020Sep 30, 2020-$0.36–
Q2 FY2020Jun 30, 2020-$0.35–
Q1 FY2020Mar 31, 2020-$0.33–
Q3 FY2019Sep 30, 2019-$2.17–
Q2 FY2019Jun 30, 2019-$1.87–
Q1 FY2019Mar 31, 2019-$6.05–
Q3 FY2018Sep 30, 2018-$9.47–

More Cabaletta Bio figures

See a number that looks wrong?